focus -WSS

focus

author：fashion 2025-09-27 23:03:15 - browse：12615

After months of vigorous deliberations, I’m thrilled to announce our 2023 STATUS List — the definitive roster of leaders in health, medicine, and the life sciences whose work over the past year has advanced those fields.

There were, of course, many contenders to choose from. For this second annual list, we’ve selected just 46 — an homage to the number of chromosomes in human DNA. Many are well-known as changemakers; others are largely unheralded heroes. They are CEOs, philanthropists, government officials, and health advocates. All have compelling stories to tell.

Our editorial team painstakingly researched and identified hundreds of finalists. In winnowing down the list, judges placed special emphasis on people who have sought to help others and build community in these often-divisive times. One note: Our news coverage is independent of this list, and we remain committed to tough-minded reporting on the people and institutions shaping life sciences.

While I have your attention, I want to point you to some of our most talked-about exclusive stories in recent days: A new STAT investigation exposes how Medicare Advantage plans use algorithms to cut off care for seniors in need, and we took a closer look at how a Medicare Advantage business is strangling one of its first funders. We’re aggressively reporting on the consequences for biotech of the Silicon Valley Bank collapse.

And over the coming months, in our series “The Obesity Revolution,” we’ll explore a class of obesity drugs that is transforming patients’ lives, dividing medical experts, and spurring one of the biggest business battles in years.

For full access to our exclusive reporting, please consider purchasing a STAT+ subscription. Get 15% off an annual subscription by using promo code STAT15 when you check out.

As always, please reach out to me with feedback. I’m at [email protected].

Previous article： Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
Next article： How housing is health care on Long Island

focus

WSS

Hospitals, health systems can help patients avoid medical debt

FDA proposes changes to key medical devices approval pathway

Walmart eyes Medicare Advantage provider ChenMed

Long Covid needs a new name — and a new frame

Trader Joe's recalls 10K cases of broccoli cheddar soup over potential foreign material

VC firm RA Capital starts a new synthetic biology incubator

leisure time

focus

knowledge

Drug repurposing or repositioning? The language matters

IRA could hurt research into orphan drugs for rare diseases

The cancer drug shortage isn’t new — and neither are the solutions

IRA could hurt research into orphan drugs for rare diseases

Psychedelics group wrestles with new pharma identity

CDC: Cases of alpha

BioMarin wins approval for gene therapy to treat hemophilia A

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

23andMe had bad news about my health. I wish a person had delivered it

'Hero' Louisville officer shot in head at mass shooting discharged over 3 months later

focus

CDC: Cases of alpha

Private equity could exacerbate cardiology's overuse problem, experts fear

New weight loss drugs vying to be the next Wegovy or Mounjaro

What to make of Biden’s latest efforts on cancer research

FDA proposes changes to key medical devices approval pathway

Will the IRA bring competition to the biologics market?

focus

Wikipedia

knowledge

entertainment